The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Ranfac sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Ranfac Corp (Ranfac) operates as a medical device company that manufactures precision medical instruments. The company’s products include percutaneous introducers, multipurpose knot pusher ligator, pneumoperitoneum insufflation needles, puncture closure devices, and others. It also provides soft tissue biopsy needles, stiffening cannulas, disposable cholangiography catheters, ranfac localization system, ranfac breast marking system, ranfac breast orientation system, ranfac breast bracketing system and galactography infusion units. Ranfac also manufactures RJN bone marrow biopsy needles, snarecoil bone marrow biopsy needles, bone marrow aspiration and access needles, bone marrow kits, removable handles and bone access technology. The company provides marrow cellution, bone marrow aspiration and access needles, fat aspiration transfer system, and a vacuum pressure handle. Ranfac is headquartered in Avon, Massachusetts, the US. Key subsidiaries of Ranfac include Cervos Medical.
The key metrics of Ranfac related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Ranfac is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Ranfac.
For a detailed understanding of the performance of Ranfac, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
